Optogenetics and its application in neural degeneration and regenerationJosue D. Ordaz, Wei Wu, Xiao-Ming Xu1197-1209
Live-cell imaging: new avenues to investigate retinal regenerationManuela Lahne, David R.Hyde1210-1219
Primary cilia as a novel horizon between neuron and environmentGregory W. Kirschen, Qiaojie Xiong1225-1230
Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous systemJulia J. Segura-Uribe, Rodolfo Pinto-Almazán, Angélica Coyoy-Salgado, Claudia E. Fuentes-Venado, Christian Guerra-Araiza1231-1240
Transcriptional inhibition in Schwann cell development and nerve regenerationSusanne Quintes, Bastian G.Brinkmann1241-1246
LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?Simon Foale, Martin Berry, Ann Logan, Daniel Fulton, Zubair Ahmed1247-1251
Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseasesMasayuki Hata, Hanako Ohashi Ikeda1252-1255
Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapyAsha Hiremathad, Luca Piemontese1256-1261
Metabolic pathways as possible therapeutic targets for progressive multiple sclerosisRebecca M. Heidker, Mitchell R. Emerson, Steven M.LeVine1262-1267
